00:43 , Jan 13, 2018 |  BioCentury  |  Finance

Choosy investors

  Despite losing steam in 4Q17, the broad-based recovery in biotech stocks last year has left investors generally comfortable with current valuations, and hence less optimistic that the sector indexes will outpace the broader market...
22:13 , Jan 5, 2018 |  BC Week In Review  |  Financial News

Axium proposes amended $5M IPO

Drug delivery company Axium Pharmaceuticals Inc. (High Point, N.C.) proposed to raise $5 million through the sale of 50 million shares at $0.10 per share in a self-underwritten IPO on Dec. 28, 2017. The proposal...